2,4,6-Tri(9H-carbazol-9-yl)-1,3,5-triazine (purified by sublimation)>98.0%(HPLC)(N)5g

6-Amino-5-(2-chloroacetyl)-1-cyclopropyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98%, 100mg

(1-(3-Chlorophenyl)-1H-pyrazol-4-yl)boronic acid, 97%, 1g

5'-(3-Formyl-4-hydroxyphenyl)-4,4''-dihydroxy-[1,1':3',1''-terphenyl]-3,3''-dicarbaldehyde, 98%, 250mg

[Bis(2-methoxyethyl)amino]sulphur trifluoride 50wt% solution in Toluene, 95.0%, 5g

4,6-Dichloro-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one, 95.0%, 1g

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 10mg

4-(4-Biphenylyl)-2-(4-pyridyl)thiazole, 250mg

2,2-Difluoro-2-(4-chlorophenyl)acetic acid, 97.0%, 2.5g

2-(2-Iodo-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 5g

4-(Thiomorpholin-4-ylmethyl)phenylboronic acid, 98%, 1g

Ethyl 4-bromo-6-methylpicolinate, 95.0%, 1g

N,N-diméthylformamide, PEPTIPURE®, min 99,8 %, pour la synthèse peptidique, 500 ml